Key facts
- It has raised $14.0M; the latest was Early Stage VC in Dec 2025.
- Notable investors include YuanBio Venture Capital, Zhehua Investment, Far East Horizon, Huaxin Capital, Ltd — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Cardioacc
- ·The full record, as it builds
Funding rounds
No funding rounds for Cardioacc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cardioacc
Developer of cardiovascular interventional imaging and treatment technologies designed to better treat patients. The company offers interventional imaging technologies such as ICE (intracardiac echocardiography) catheter imaging and develops high-resolution surgical imaging and navigation tools, enabling patients with cardiac surgery to have safe and economic intraoperative imaging methods.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Employees
- 40
- Website
- cardioacc.com/
- Ownership
- Privately Held (backing)
Cardioacc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cardioacc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cardioacc in its N-PORT filings yet. We sweep new filings monthly.